$SRNE *be informed* Sorrento now has 6 trials registered that are pending start. Although many clinical trials have stopped or limited recruiting during the pandemic, expect their lead asset, Resiniferatoxin, to have its P3 pivotal trial in knee replacement deferment to start soon.
  • 6
6 Likes